Gilead disputes data leak showing its drug failed to improve the conditions of COVID-19 patients

A US pharmaceutical company is disputing reports that its experimental antiviral drug failed to help patients patients with severe cases of the novel coronavirus. On Thursday, the World Health Organization (WHO) prematurely posted a draft summary of a trial of the drug remdesivir, made by California-based Gilead Sciences. Originally developed as a treatment for Ebola, the … Read more